UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005250
Receipt number R000006242
Scientific Title Efficacy of ezetimibe for the treatment of non-alcoholic fatty liver disease: A randomized, controlled trial
Date of disclosure of the study information 2011/03/14
Last modified on 2011/03/14 23:16:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of ezetimibe for the treatment of non-alcoholic fatty liver disease: A randomized, controlled trial

Acronym

Efficacy of ezetimibe for the treatment of non-alcoholic fatty liver disease: A randomized, controlled trial

Scientific Title

Efficacy of ezetimibe for the treatment of non-alcoholic fatty liver disease: A randomized, controlled trial

Scientific Title:Acronym

Efficacy of ezetimibe for the treatment of non-alcoholic fatty liver disease: A randomized, controlled trial

Region

Japan


Condition

Condition

non-alcoholic fatty liver disease

Classification by specialty

Hepato-biliary-pancreatic medicine Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

We therefore investigated the efficacy of Ezetimibe treatment for NAFLD patients by an open-label randomized, controlled trial. In this study, we compared the alterations of not only clinical parameters but also histological findings.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Clinical parameters and liver histologyin NAFLD were evaluated before and after the treatment

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Ezetimibe

Interventions/Control_2

control

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1) NAFLD in histology
2) dyslipidemia TC 220mg/dl or higher
or treatment to dyslipidemia has already been done.
3) Case it is possible to take ezetimibe about six months
4) Child-Pugh A
5) 20-80 years old age when registering
6) Performance status(ECOG scale) is 0 or 1
7) Key organ function is maintained by clinical examination within 14 days before it registers.

Key exclusion criteria

Patients will be excluded from the study if they meet any of the following criteria:
1)hepatic virus infections (hepatitis B and C)
2)the current or past consumption of more than 20 g of alcohol daily
3)concurrent hepatocellular carcinoma, as determined by diagnostic imaging results
4) hepatic encephalopathy
5) active infections
6) severe complication
7) Woman who has possibility of pregnancy or pregnancy or while suckling.
8)Case to whom medicine in which it is using together taboo of ezetimibe and describes attention of using together is administered
9) those who are inadequate for this study as assessed by the investigators

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Eishiro Mizukoshi

Organization

Kananzawa University Graduate School of Medical Science

Division name

Department of Disease Control and Homeostasis

Zip code


Address

13-1 Takara-machi, Kanazawa

TEL

076-265-2233

Email



Public contact

Name of contact person

1st name
Middle name
Last name Eishiro Mizukoshi

Organization

Kananzawa University Graduate School of Medical Science

Division name

Department of Disease Control and Homeostasis

Zip code


Address

13-1 Takara-machi, Kanazawa

TEL


Homepage URL


Email



Sponsor or person

Institute

Eishiro Mizukoshi

Institute

Department

Personal name



Funding Source

Organization

Kanazawa University Graduate School of Medical Science

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

金沢大学医学部附属病院 (石川県)


Other administrative information

Date of disclosure of the study information

2011 Year 03 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2008 Year 04 Month 01 Day

Last follow-up date

2011 Year 02 Month 01 Day

Date of closure to data entry

2011 Year 02 Month 01 Day

Date trial data considered complete

2011 Year 02 Month 01 Day

Date analysis concluded

2011 Year 02 Month 01 Day


Other

Other related information



Management information

Registered date

2011 Year 03 Month 14 Day

Last modified on

2011 Year 03 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006242


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name